Healthcare Equipment and Supplies
Company Overview of BioMedical Enterprises, Inc.
BioMedical Enterprises, Inc., an orthopedic medical device company, manufactures and markets orthopedic shape memory implants in the United States. It offers intramedullary implant systems, heat-activated shape memory staples, nitinol bone staples, and shape memory bone fusion implants for various procedures, including hammertoe, hallux valgus, flatfoot, other foot conditions, wrist arthritis, hand arthritis, and high tibial osteotomy. The company was founded in 1991 and is based in San Antonio, Texas.
14785 Omicron Drive
San Antonio, TX 78245
Founded in 1991
Key Executives for BioMedical Enterprises, Inc.
Chief Executive Officer, President and Director
Director of Finance & Administration
Vice President of Operations
Vice President of Business Development and Marketing
Compensation as of Fiscal Year 2014.
BioMedical Enterprises, Inc. Key Developments
BioMedical Enterprises Launches the Speed Titan™ Nitinol Bone Fixation Implant With Breakthrough Tapered Body Design
Apr 1 15
BioMedical Enterprises, Inc. announced the launch of the Speed Titan™ Nitinol Bone Fixation Implant. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc™ and Speed Shift™ implants. The Speed Titan implant, with a breakthrough tapered body design, has a wider, low-profile bridge, for higher strength and compression. This new Speed Titan implant provides more compression than the leading Nitinol implant competitor. The Speed Titan’s wider bridge tapers into narrower legs, making the Speed Titan ideal for high-load, mid-foot applications where there may be limited space for fixation. The Speed Titan implant comes ready-to-use on a pre- loaded insertion tool. Just like BME’s patented Speed system, the Speed Titan utilizes pre-sterilized, fully disposable instrumentation for exceptional efficiencies in the operating room.
BioMedical Enterprises, Inc. Introduces Surgeon Advisory Board for the Upper Extremity Market
Feb 24 15
BioMedical Enterprises announced the creation of its Hand and Wrist Surgeon Advisory Board. This new team will use their collective experience to guide BME's product pipeline and ensure that these products live up to the quality and efficiency standards which are synonymous with BME. As thought leaders, they will also support BME in educating other physicians on the benefits of Nitinol technologies and lead various research initiatives. These physicians, chosen for their expertise in the field, will help BME achieve greater breadth and depth of product offering in the upper extremity market. The BME Hand and Wrist Surgeon Advisory Board members: David Beard, M.D. – Orthopaedic Surgeon, Department of Orthopedic Surgery, Essentia Health Care System; Fargo, ND. R. Glenn Gaston, M.D. – Chief of Hand Surgery, Carolinas Medical Center, Hand Fellowship Director, OrthoCarolina; Charlotte, NC. Jeffrey Greenberg, M.D., M.S. – Partner, Indiana Hand to Shoulder Center, Clinical Assistant Professor, Indiana University Department of Orthopedic Surgery; Indianapolis, IN. Steve K. Lee, M.D. – Associate Professor of Orthopaedic Surgery Hand, Upper Extremity, and Microsurgery Director of Research, Center for Brachial Plexus and Traumatic Nerve Injury, Hospital for Special Surgery (HSS), Weill Medical College of Cornell University; New York, NY. Jeffrey Yao, M.D. – Associate Professor of Orthopaedic Surgery and Surgery Robert A. Chase Hand and Upper Limb Center, Stanford University Medical Center; Redwood City, CA.
BioMedical Enterprises Launches the HammerLock(R) 2 Intramedullary Nitinol Fixation System
Nov 3 14
BioMedical Enterprises announced the launch of the HammerLock(R) 2 Intramedullary Nitinol Fixation System. This is the long-awaited next generation of the popular HammerLock implant with innovative Nitinol technology--designed to provide surgeons with an intramedullary implant that does not require freezing. This significant advancement allows surgeons to take advantage of the compressive benefits of Nitinol fixation while simplifying the logistics inside the operating room. The new HammerLock 2 is an effective solution for hammertoe fixation. It is designed to fit a wider range of anatomies, and with many points of stabilization within the toe, preventing rotation. Most importantly, the HammerLock 2 system, like the patented BME Speed Fixation System, comes in pre-sterilized, fully disposable implant and instrument kits that enhance efficiencies in the operating room. This patent-pending implant and system represent BME's commitment to developing, manufacturing and marketing the best solutions possible for institutions, surgeons and patients. The new BME HammerLock 2 Intramedullary Nitinol Fixation System is available now for commercial use throughout the United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|